Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$724.87 - $909.04 $1.67 Million - $2.09 Million
-2,300 Reduced 85.19%
400 $362,000
Q1 2024

May 10, 2024

SELL
$592.2 - $792.28 $4.03 Million - $5.39 Million
-6,800 Reduced 71.58%
2,700 $2.1 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $472,671 - $557,217
900 Added 10.47%
9,500 $5.54 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $3.74 Million - $5.15 Million
8,600 New
8,600 $4.62 Million
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $6.43 Million - $7.49 Million
20,000 New
20,000 $7.32 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $859B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tcg Advisory Services, LLC Portfolio

Follow Tcg Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Advisory Services, LLC with notifications on news.